Prostate Cancer International is
for 2011 by Great NonProfits
High-intensity focused ultrasound (HIFU) is approved in Canada for the treatment of localized prostate cancer. Since its approval, this form of treatment has become popular among patients seeking a potentially curative form of treatment with low risk for complications and side effects.
Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: failure, HIFU, high-intensity focuse ultrasound, outcome, salvage, surgery | Leave a Comment »
RTOG 96-01 is a randomized, multi-center Phase III trial designed to compare bicalutamide monotherapy + salvage radiation therapy to a placebo + salvage radiation alone in men with pT2-3N0Mo prostate cancer who have an elevated PSA after surgery.
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: bicalutamide, outcome, radiation, RTOG 96-01, salvage | 2 Comments »
Men with high-risk, localized prostate cancer who decide on surgery as their first-line treatment of choice are sometimes faced with the question of whether to undergo “immediate” adjuvant radiation therapy after their surgery or to do nothing and wait to see if salvage radiation therapy becomes necessary.
Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: adjuvant, outcome, prostatectomy, radiation, salvage | Leave a Comment »
In March 2009, Thompson et al. published data from the SWOG 8794 trial showing that adjuvant radiation therapy immediately post-surgery significantly improved the oncologic outcomes of men with pathologic T3N0M0 prostate cancer compared to later salvage radiation, but
Filed under: Management, Treatment | Tagged: adjuvant, post-surgery, radiation, salvage, surgical margins, T3 disease | 4 Comments »
One of the problems of first-line radiation therapy is how to treat patients with a rising PSA (biochemical relapse) after it becomes clear that the rise in PSA is not simply a “biochemical bounce” in the PSA.
Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: cryotherapy, outcome, prognosis, salvage | Leave a Comment »
One of the proposed uses for high-intensity focused ultrasound (HIFU) has been as a treatment option for men with a rising PSA after first-line treatment with external beam radiation therapy (EBRT).
Filed under: Management, Treatment | Tagged: failure, HIFU, high-intensity focused ultrasound, outcome, radiation, salvage | Leave a Comment »
Today’s news reports address: Daily fat intake and risk for prostate cancer Salvage RALP as a treatment for patients in biochemical relapse after first-line EBRT Phase II data on fenretinide as a possible treatment for HRPC
Filed under: Drugs in development, Management, Prevention, Risk, Treatment | Tagged: fat intake, fatty acids, fenretinide, MUFA, PUFA, RALP, robot-assisted laparoscopic prostatectomy, salvage, SFA | Leave a Comment »
In today’s news reports we comment on articles dealing with: The declining rate of prostate cancer mortality in the USA Managing prostate cancer in the elderly Re-validation of the Partin tables RALP as salvage surgery for radiation-resistant patients
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: elderly, mortality rates, Partin tables, RALP, salvage | 7 Comments »
A long-term study from the Mayo Clinic reports a low incidence of complications (other than erectile dysfunction) following salvage radiotherapy for men with prostate cancer recurrence after an initial radical prostatectomy.
Filed under: Management, Treatment | Tagged: EBRT, post-surgery, radiation, salvage | Leave a Comment »
A new study from a group at Duke University has attempted to assess whether data based on PSA doubling times in men with PSA levels up to 0.2 ng/ml can be used as effectively to make early treatment decisions for men with a rising PSA after first-line therapy as can PSA doubling times for men [...]
Filed under: Living with Prostate Cancer, Management | Tagged: early, PSA doubling time, PSADT, radical prostatectomy, salvage | Leave a Comment »
In today’s news reports we address new data on: The possible association between PSA levels and SNPs Patient age at diagnosis and prostate cancer outcomes Revalidation of the Stephenson nomogram for outcomes after salvage radiation therapy Failure to follow best practices for radiation of bony metastases
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: age, best practices, Diagnosis, external beam radiation, nomogram, PSA, salvage, single nucleotide polymorphism, SNP | Leave a Comment »
Today’s news reports deal with such items as: Genomic testing for prostate cancer and the value of specific SNPs What do pre-treatment MRI/MRSI tests and molecular profiling add to prognostic significance? Quality of life following salvage brachytherapy
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: brachytherapy, Diagnosis, genome, MRI, MRSI, prognosis, quality of life, salvage, SNPs | 2 Comments »
A Canadian group has just added a little more to our knowledge about the role of neoadjuvant hormone therapy in association with radiotherapy after first-line radical prostatectomy (RP).
Filed under: Management, Treatment, Uncategorized | Tagged: androgen deprivation therapy, neoadjuvant, radiotherapy, salvage | Leave a Comment »
And still the stream of information continues, with reports about frequency of PSA testing, nerve-sparing in men with Gleason 6 disease, and HIFU as a form of salvage therapy after first-line radiation:
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: frequency, HIFU, nerve-sparing, salvage, screening | 2 Comments »
Wednesday’s news reports include items on: The occurrence of “clinically insignificant” prostate cancer in an autopsy series The value of a patient decision aid in management of localized prostate cancer The clinical value of the 2005 International Society of Urologic Pathology Gleason Grading Consensus score (ISUP GS) Outcomes of radical prostatectomy for prostate cancer discovered [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: clinically insignificant, decision aid, Gleason grading, RALP, salvage, TURP | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site